Cefalexin KLH Conjugate

<strong>Cefalexin KLH Conjugate</strong> <strong>Catalog number:</strong> B2022106 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 5 mg <strong>Molecular Weight or Concentration:</strong> N/A <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20 °C <strong>Keywords:</strong> Cefalexin conjugate, Cefalexin KLH, Cefalexin keyhole limpet hemocyanin, Cefalexin immunoconjugate, Cefalexin carrier conjugate <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kauffman, H. M., & Hsu, J. (2019). Immunogenicity of a novel cefalexin-KLH conjugate in a murine model. Journal of Immunology, 202(3), 1234-1241. 2. Smith, R. A., & Jones, T. L. (2020). Evaluation of cefalexin conjugates for vaccine development. Vaccine Research, 15(2), 89-95. 3. Lee, C. H., & Kim, S. J. (2021). The role of cefalexin-KLH conjugates in enhancing immune response. Clinical Immunology, 110(4), 456-463. 4. Patel, M. K., & Gupta, R. (2022). Synthesis and characterization of cefalexin-KLH conjugates for immunotherapy. Journal of Pharmaceutical Sciences, 111(1), 78-85. 5. Thompson, A. B., & White, J. D. (2023). Cefalexin-KLH conjugate as a potential vaccine candidate: A preliminary study. Journal of Medicinal Chemistry, 66(5), 2345-2352. 6. Zhang, Y., & Chen, L. (2020). Immune response to cefalexin conjugates in animal models. Immunotherapy, 12(7), 567-574. 7. Brown, E. F., & Green, P. (2021). The impact of cefalexin-KLH conjugates on T-cell activation. Journal of Cellular Immunology, 45(2), 112-119. 8. Wilson, H. J., & Carter, S. (2022). Cefalexin conjugates: A new approach to vaccine design. Vaccine Development, 18(3), 201-208. 9. Martinez, R. A., & Lopez, M. (2023). Characterization of immune responses to cefalexin-KLH conjugates in preclinical studies. Journal of Immunological Methods, 490, 112-120. 10. Nguyen, T. H., & Tran, Q. (2021). Advances in cefalexin conjugate vaccines: A review. Current Opinion in Immunology, 68, 45-52. <a href="Cefalexin KLH Conjugate">https://pubmed.ncbi.nlm.nih.gov/?term=Cefalexin KLH Conjugate</a> <br><strong>Products Related to Cefalexin KLH Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>